MONTREAL (AP) — MONTREAL (AP) — Milestone Pharmaceuticals Inc. (MIST) on Tuesday reported a loss of $9.4 million in its third quarter. The Montreal-based company said it had a loss of 14 cents per ...
MONTREAL and CHARLOTTE, N.C., Nov. 12, 2024 (GLOBE NEWSWIRE) -- Milestone ® Pharmaceuticals Inc. (Nasdaq: MIST) today reported financial results for the third quarter ended September 30, 2024 and ...
Some results have been hidden because they may be inaccessible to you